BODALCHEM — Bodal Chemicals Balance Sheet
0.000.00%
- IN₹21.00bn
- IN₹28.55bn
- IN₹20.12bn
Annual balance sheet for Bodal Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 94 | 168 | 369 | 234 | 168 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6,361 | 4,819 | 4,457 | 4,653 | 5,138 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 11,308 | 8,509 | 8,135 | 8,980 | 9,344 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 8,708 | 11,461 | 13,678 | 13,496 | 12,942 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 21,223 | 21,209 | 22,879 | 23,529 | 23,558 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8,044 | 6,214 | 6,944 | 7,669 | 7,616 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 10,665 | 10,432 | 12,056 | 12,481 | 11,982 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 10,558 | 10,777 | 10,822 | 11,048 | 11,575 |
| Total Liabilities & Shareholders' Equity | 21,223 | 21,209 | 22,879 | 23,529 | 23,558 |
| Total Common Shares Outstanding |